What is Eiko Lifesciences share price return in the past 10 years?

Data is not available for this company

Eiko Lifesciences Ltd - Stock Valuation and Financial Performance

Name: Eiko Lifesciences
Brand: Eiko Lifesciences

BSE: 540204 | NSE: | Chemicals | Small Cap

Place order

Eiko Lifesciences Share Price

₹60.19 -1.55 -2.51%
as on 30-Dec'24 16:59

DeciZen - make an informed investing decision on Eiko Lifesciences

Based on:

Data

M-Cap below 100cr DeciZen not available

Eiko Lifesciences stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

77.44

Market Cap:

85.6 Cr.

52-wk low:

45.1

52-wk high:

81.3

Is Eiko Lifesciences Ltd an attractive stock to invest in?

1. Is Eiko Lifesciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Eiko Lifesciences Ltd is a below average quality company.

2. Is Eiko Lifesciences Ltd undervalued or overvalued?

The key valuation ratios of Eiko Lifesciences Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Eiko Lifesciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Eiko Lifesciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Eiko Lifesciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	1.6%	3.5%	6.8%	5.6%	2.3%	3.5%	9.2%	6%	3.8%	2.8%	-
Value Creation Index ⓘ	-0.9	-0.8	-0.5	-0.6	-0.8	-0.8	-0.3	-0.6	-0.7	-0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.1	0.6	0.4	0.5	0.4	0	12	25.4	18.3	27.9	34
Sales YoY Gr.	-	409.1%	-28.6%	22.5%	-26.5%	-100%	NA	111.9%	-27.9%	52.5%	-
Adj EPS ⓘ	0.1	0.2	0.5	0.4	0.2	0.2	1.3	0.7	0.7	0.6	0.8
YoY Gr.	-	360%	113%	-16.3%	-61%	31.3%	523.8%	-44.3%	-2.7%	-22.5%	-
BVPS (₹) ⓘ	8.7	9	9.3	12.6	12.3	12.4	14	29.8	30.7	39.4	37.7
Adj Net Profit ⓘ	0	0.1	0.2	0.2	0.1	0.1	0.6	0.7	0.7	0.8	1
Cash Flow from Ops. ⓘ	-0.1	0.2	0.2	0.2	-0.2	0.8	-0.8	-7.7	4.2	-7.1	-
Debt/CF from Ops. ⓘ	0	1.3	2.2	1.5	-1.6	0.3	-2.2	-0.6	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	85%	138.8%	32.6%	52.5%
Adj EPS ⓘ	30.5%	28%	-25.1%	-22.5%
BVPSⓘ	18.2%	26.2%	41.1%	28.4%
Share Price	-	34.6%	-3.3%	-6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	1.1	2.6	5.4	4.2	1.3	1.7	6.4	3.4	2.3	1.9	2.1
Op. Profit Mgn % ⓘ	24.4	16.9	64.8	62.8	47	0	4.4	5.2	5.2	5.8	5.1
Net Profit Mgn % ⓘ	16.1	14.3	43	37.1	19.8	0	4.8	2.8	3.7	2.7	3.3
Debt to Equity ⓘ	0	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0	0	0
Working Cap Days ⓘ	4,803	994	504	758	2,239	0	258	232	365	250	169
Cash Conv. Cycle ⓘ	213	31	0	-1	41	0	23	74	153	145	157

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 32.56%

Sales growth is good in last 4 quarters at 41.07%

Return on Equity has declined versus last 3 years average to 2.10%

Latest Financials - Eiko Lifesciences Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.8	-0.7
TTM Sales (₹ Cr.)	33.5	5.2
BVPS (₹.) ⓘ	37.7	0
Reserves (₹ Cr.) ⓘ	38	38
P/BV ⓘ	1.64	0.00
PE ⓘ	77.44	0.00

From the Market
52 Week Low / High (₹)	45.10 / 81.32
All Time Low / High (₹)	6.64 / 95.33
Market Cap (₹ Cr.)	85.6
Equity (₹ Cr.)	13.9
Face Value (₹)	10
Industry PE ⓘ	57.2

Management X-Ray of Eiko Lifesciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Eiko Lifesciences

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Eiko Lifesciences

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	0.11	0.56	0.40	0.49	0.36	0	11.99	25.41	18.32	27.93
Operating Expenses ⓘ	0.08	0.46	0.14	0.18	0.19	0.17	11.47	24.10	17.36	26.32
Manufacturing Costs	0	0	0	0	0	0	0.47	0.84	0.54	0.21
Material Costs	0	0	0	0	0	0	10.61	22.58	16.09	25.41
Employee Cost	0	0.10	0.06	0.07	0.02	0.07	0.12	0.23	0.23	0.16
Other Costs ⓘ	0.08	0.36	0.08	0.11	0.17	0.10	0.27	0.45	0.50	0.53
Operating Profit ⓘ	0.03	0.09	0.26	0.31	0.17	-0.17	0.52	1.31	0.96	1.61
Operating Profit Margin (%)	24.4%	16.9%	64.8%	62.8%	47.0%	-	4.4%	5.1%	5.2%	5.8%
Other Income ⓘ	0	0.02	0	0.02	0.02	0.43	0.46	0.67	0.85	0.18
Interest ⓘ	0	0	0.02	0.05	0.03	0.07	0.09	0.48	0.16	0.15
Depreciation ⓘ	0	0	0.02	0.06	0.06	0.06	0.06	0.56	0.63	0.66
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.03	0.11	0.22	0.22	0.10	0.13	0.83	0.94	1.03	0.98
Tax ⓘ	0.01	0.03	0.05	0.04	0.03	0	0.22	0.24	0.26	0.23
Profit After Tax	0.02	0.08	0.17	0.18	0.07	0.13	0.61	0.71	0.77	0.75
PAT Margin (%)	16.1%	14.3%	43.0%	37.1%	19.8%	-	5.1%	2.8%	4.2%	2.7%
Adjusted EPS (₹)	0.1	0.2	0.5	0.4	0.2	0.3	1.4	0.7	0.8	0.6
Dividend Payout Ratio (%)	0%	0%	44%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	3.04	3.12	3.23	5.55	5.43	5.48	6.19	28.63	29.42	50.68
Share Capital ⓘ	3.02	3.02	3.02	3.82	3.82	3.82	3.82	8.32	8.32	12.87
Reserves ⓘ	0.02	0.10	0.21	1.73	1.61	1.66	2.37	20.31	21.11	37.81
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0.25	0.37	0.31	0.26	0.20	1.76	4.55	0	0
Long Term Debt	0	0	0.37	0.31	0.26	0.20	0.13	0.05	0	0
Short Term Debt	0	0.25	0	0	0	0	1.63	4.50	0	0
Trade Payables	0	0	0	0	0	0	1.90	1.35	1.05	1.38
Others Liabilities ⓘ	0.01	0.02	0.17	0.12	0.07	0.03	6.75	0.36	0.58	0.68
Total Liabilities ⓘ	3.04	3.39	3.76	5.98	5.76	5.71	16.59	34.89	31.04	52.74
Fixed Assets
Gross Block	0	0	0.52	0.52	0.52	0.52	0.52	15.12	15.34	15.68
Accumulated Depreciation	0	0	0.02	0.08	0.14	0.21	0.27	0.83	1.46	2.12
Net Fixed Assetsⓘ	0	0	0.49	0.43	0.37	0.31	0.25	14.29	13.88	13.57
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0.26	2.59	2.45	3.58	2.13	0.50	0.22	0.20	0.05	4.02
Inventories	0	0	0	0	0	0	0.06	5.46	0.91	3.39
Trade Receivables	0.10	0	0	0	0.08	0	3.41	4.56	7.11	13.13
Cash Equivalents	0.02	0.51	0.01	0.73	0.03	0.02	4.07	0.22	0.61	13.35
Others Assetsⓘ	2.67	0.28	0.81	1.24	3.15	4.88	8.57	10.17	8.48	5.29
Total Assets ⓘ	3.04	3.39	3.76	5.98	5.76	5.71	16.59	34.89	31.04	52.74

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-0.05	0.19	0.19	0.24	-0.19	0.77	-0.83	-7.73	4.22	-7.08
PBT ⓘ	0.03	0.11	0.22	0.22	0.10	0.13	0.83	0.94	1.03	0.98
Adjustment ⓘ	0	0	0.04	0.11	0.07	0.06	-0.21	0.38	0.02	0.62
Changes in Working Capital ⓘ	-0.06	0.1	-0.01	-0.05	-0.33	0.6	-1.27	-8.84	3.1	-8.65
Tax Paid ⓘ	-0.01	-0.02	-0.06	-0.04	-0.03	-0.01	-0.18	-0.21	0.08	-0.03
Cash Flow From Investing Activity ⓘ	-2.75	0.05	-0.38	-1.33	-0.43	-0.65	-2.94	0.59	0.87	-0.55
Capex	0	0	-0.52	0	0	0	0	-0.15	-0.22	-0.35
Net Investments	-0.10	-2.33	0.18	-0.51	-0.10	1.58	0.40	0	0.37	-0.38
Others ⓘ	-2.65	2.38	-0.05	-0.82	-0.33	-2.23	-3.34	0.75	0.73	0.18
Cash Flow From Financing Activityⓘ	2.80	0.25	0.15	1.82	-0.08	-0.13	7.81	3.28	-4.70	20.36
Net Proceeds from Shares ⓘ	2.82	0	0	2	0	0	0	0.95	0	20.50
Net Proceeds from Borrowing ⓘ	0	0	0.41	-0.05	-0.05	-0.06	1.56	2.79	-4.55	0
Interest Paid ⓘ	0	0	-0.01	-0.05	-0.03	-0.07	-0.09	-0.46	-0.15	-0.14
Dividend Paid ⓘ	0	0	0	-0.09	0	0	0	0	0	0
Others ⓘ	-0.02	0.25	-0.25	0	0	0	6.34	0	0	0
Net Cash Flow ⓘ	0.01	0.49	-0.04	0.72	-0.71	-0.01	4.05	-3.85	0.40	12.73

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	1.06	2.6	5.35	4.16	1.32	2.34	10.53	4.05	2.65	1.88
ROCE (%)	1.6	3.53	6.83	5.6	2.25	3.46	9.18	5.96	3.77	2.82
Asset Turnover Ratio	0.07	0.17	0.11	0.1	0.06	0	1.08	0.99	0.56	0.67
PAT to CFO Conversion(x)	-2.5	2.38	1.12	1.33	-2.71	5.92	-1.36	-10.89	5.48	-9.44
Working Capital Days
Receivable Days	213	0	0	0	85	0	104	57	116	132
Inventory Days	0	0	0	0	0	0	2	40	63	28
Payable Days	0	0	0	0	0	0	33	26	27	17

Eiko Lifesciences Ltd Stock News

Eiko Lifesciences Ltd FAQs

What is the share price of Eiko Lifesciences?

Company share prices are keep on changing according to the market conditions. The closing price of Eiko Lifesciences on 30-Dec-2024 16:59 is ₹60.19.

What is the market cap of Eiko Lifesciences?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 30-Dec-2024 16:59 the market cap of Eiko Lifesciences stood at ₹85.57.